BNET Industries
Last Fiscal Year Sales:$68.5M
- Private
- US
Dow Jones Description
Cardiac Science, Inc. develops, manufactures and markets life-saving automated external cardiac defibrillators for both the in-hospital and public access markets that address the leading cause of death in the United States sudden cardiac arrest (SCA). Each year, over 450,000 Americans die from SCA. Approximately 70 percent of the deaths occur while people are at work, home or play and nearly 30 percent in hospitals. Outside the hospital, only 5 percent of the SCA victims survive this very treatable condition, with in-hospital SCA survival rates at only 15 percent. The reasons for these dismal survival rates are simple and disturbing. When a person is in cardiac arrest, oxygen is no longer reaching the brain and blood flowing to vital organs has ceased. CPR works to temporarily circulate blood throughout the body, but cannot restore a patient's heart to a life-sustaining rhythm...
Chairman & CEO
Raymond W. CohenNumber of Employees 212
Peer Companies
NAICS Code Administrative Management and General Management Consulting Services: 541611
News & Analysis
Filter by
cardiac science inc. - All News and Analysis
Cardiac Science Reports Q2 Revenue; Resumes AED Shipments
Operating Cash Flow of $0.5 Million and Net Loss of $0.09 per Share BOTHELL, Wash., Aug. 10 /PRNewswire-FirstCall/ -- Cardiac Science Corporation , a global leader in automated external defibrillator AED and diagnostic cardiac monitoring devices, today announced that revenue for the second quarter ended June...
Patriot Scientific Corporation Announces Cardiac Science Corporation's Purchase of a Moore Microprocessor PatentÂ? Portfolio License
CARLSBAD, Calif., July 29 /PRNewswire-FirstCall/ -- Patriot Scientific Corporation (BULLETIN BOARD:PTSC) announced today that Cardiac Science Corporation has purchased a Moore Microprocessor PatentTM MMP Portfolio license from The TPL Group. Cardiac Science develops, manufactures, and markets automated external defibrillators AEDs, electrocardiograph devices ECGs,...
Cardiac Science to Present at Needham Biotechnology & Medical Technology Conference
BOTHELL, Wash., June 4 /PRNewswire-FirstCall/ -- Cardiac Science Corporation , a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, announced it will present at the Eighth Annual Needham & Company Biotechnology and Medical Technology Conference at the New York Palace Hotel. Dave Marver, president...
Weak sales result in job cuts at Cardiac Science
Cardiac resuscitation and diagnostic equipment manufacturer Cardiac Science cut 12 percent of its staff, or about 66 employees, due to a weak sales outlook. While the Bothell, Wash.-based firm reported record 2008 revenue of $206.2 million, executives forecast weak sales and "slower demand" this year due to...
Cardiac Science promotes Marver to president, CEO
Cardiac Science has promoted Dave Marver to president and CEO from COO. John Hinson, the company's current CEO, left last month for personal reasons, according to the Denmark-based firm. [ILLUSTRATION OMITTED] Marver joined Cardiac Science as its COO in October 2008. He assumed Hinson's spot on...
Cardiac Science Selects Pentaho to Streamline Information Integration
Pentaho Corp., the commercial open source alternative for business intelligence , today announced that Cardiac Science (NASDAQ: CSCX), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, selected Pentaho Data Integration Enterprise Edition to populate and maintain its enterprise data warehouse to...
Cardiac Science
The Russell 3000 Index selected Cardiac Science Corp. to be included among its performance list of the largest 3,000 U.S. companies. The index is constructed to provide a comprehensive, unbiased and stable barometer of the broad market and is reconstituted annually. John Hinson, president and CEO of the company, says...
Cardiac Science to cut jobs
Cardiac Science, a maker of cardiac resuscitation and diagnostic equipment, has said a weakening sales outlook is forcing it to slash about 66 employees, or 12 percent, from its payroll this quarter. The Bothell, Wash.-based company said its business was solid in the fourth quarter, and that...
Boy Scouts of America and Cardiac Science Partner to Distribute AEDs
BOTHELL, Wash. & IRVING, Texas -- Cardiac Science and the Boy Scouts of America BSA have entered an alliance to make automated external defibrillators AEDs available to the BSA's camping and recreation facilities and council offices nationwide. Cardiac Science [NASDAQ:CSCX] is a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation,...
Cardiac Science Announces Board of Directors Transition
BOTHELL, Wash. -- Cardiac Science (NASDAQ:CSCX) a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, announced that the Board of Directors accepted the resignation of two directors, and appointed a new director, at its regularly scheduled meeting last week. As a result of these changes, the total...
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Howard Evers | President & COO |
| Dongping Lin | Chief Software Architect & Intellectual Property Officer |
| Kenneth F. Olson | CTO |
| Michael Gioffredi | Chief Marketing Officer |
| Prabodh Mathur | Chief Prod Development Officer |
| Guy Sohie | Senior Vice President, Operations |
| Allan Criss | |
| Brian R Lee | |
| Bruce J. Barclay | |
| Cheryl L Shea | |
| Darryl R. Lustig | |
| David M Hadley | |
| Harvey N Gillis | |
| Jeffery F. O'Donnell | |
| John R Hinson | |
| Jue Hsien Chern | |
| Kurt Lemvigh | |
| Michael K Matysik | |
| Paul Kamps | |
| Peter Foster | |
| Robert Berg | |
| Ruediger Naumann-Etienne |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Raymond W. Cohen | Chairman & CEO |
| Bruce J. Baraclay | Board of Directors |
| Peter Crosby | Board of Directors |
| Ray E. Newton | Board of Directors |
| Roderick de Greef | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Cardiac Science, Inc. | Chairman & CEO | Current |
| Execsavvy LLC | Current | |
| Cardiac Science, Inc. | Board of Directors | Current |
| Bioanalogics | President | Former |
| State University of New York at Binghamton | B.S. in Business Management | Former |
| Organization | Position | Status |
|---|---|---|
| Cardiac Science, Inc. | President & COO | Current |
| Cardiac Science, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Cardiac Science, Inc. | Chief Software Architect & Intellectual Property Officer | Current |
| Organization | Position | Status |
|---|---|---|
| Cardiac Science, Inc. | CTO | Current |
| Organization | Position | Status |
|---|---|---|
| Cardiac Science, Inc. | Chief Marketing Officer | Current |
| Organization | Position | Status |
|---|---|---|
| Cardiac Science, Inc. | Chief Prod Development Officer | Current |
| Organization | Position | Status |
|---|---|---|
| Cardiac Science, Inc. | Senior Vice President, Operations | Current |
| Organization | Position | Status |
|---|---|---|
| Cardiac Science, Inc. | Current | |
| Philips Medical Systems | Vice President | Former |
| Advanced Imaging Technologies, Inc. | Vice President, Sales and Marketing | Former |
| Indiana University of Pennsylvania | B.S. in Marketing | Former |
| Organization | Position | Status |
|---|---|---|
| Cardiac Science, Inc. | Current | |
| University of Oregon | BA and MA degrees in Physics | Former |
Bruce J Barclay joined SurModics as its President and Chief Operating Officer in December 2003. He was elected to President and Chief Executive Officer effective July 1, 2005. Prior to joining SurModics, he served as President and Chief Executive Officer of Vascular Architects, Inc., a medical device company that develops, manufactures and sells products to treat peripheral vascular disease, from 2000 to 2003. Mr. Barclay has more than 20 years of experience in the health care industry. Prior to Vascular Architects, he served at Guidant Corporation, most recently as an officer and Senior Vice President from 1998 to 2000. Previously, he was a Vice President of Guidant's Interventional Cardiology division with responsibility for the law division, a new therapies technical development team, and business development, charged with the acquisition of new products and technologies for the division. Mr. Barclay also has considerable experience in the pharmaceutical area serving in several positions at Eli Lilly and Company. Mr. Barclay received a B.S. in Chemistry and a B.A. in Biology from Purdue University in 1980 and a J.D. from Indiana University School of Law in 1984. He is also a registered patent attorney. Back to Top
| Organization | Position | Status |
|---|---|---|
| SurModics, Inc. | Director, President and Chief Executive Officer | Current |
| Cardiac Science, Inc. | Current | |
| SurModics, Inc. | Board of Directors | Current |
| Vascular Architects, Inc. | Chief Executive Officer | Former |
| Vascular Architects, Inc. | President | Former |
| Guidant Corporation | Senior Vice President | Former |
| Guidant Corporation | Vice President of Guidant's Interventional Cardiology Division | Former |
| Guidant Corporation | Officer | Former |
| Indiana University | J.D. | Former |
| Indiana University School of Law | J.D. | Former |
| Purdue University | B.A. In Biology | Former |
| Indiana University School of Law | B.S. In Chemistry | Former |
| Organization | Position | Status |
|---|---|---|
| Cardiac Science, Inc. | Current | |
| Confirma, Inc. | Vice President | Former |
| Cryogen, Inc. | Vice President | Former |
| ArthroCare Corporation | Director | Former |
| California State University | B.S. in Nursing | Former |
Darryl R. Lustig was appointed Vice President, Cardiology Sales, North America, in March 2007, after serving as Vice President, Primary Care since September 2005. Mr. Lustig previously served as Vice President, Primary Care for Quinton Cardiology Systems from March 2003 to August 2005. Prior to that, he served as Vice President, Sales and Marketing from September 2000 to March 2003 for Burdick, Inc., a company Quinton acquired in January 2003. From November 1999 to August 2000, Mr. Lustig was Vice President of Sales for Cimtek Commerce, a healthcare information and e-commerce company. Mr. Lustig has over 25 years experience in healthcare manufacturing and distribution. Mr. Lustig holds a B.A. in Political Science with a minor concentration in Advertising from Southern Illinois University.
| Organization | Position | Status |
|---|---|---|
| Burdick | Vice President, Cardiology Sales, North America | Current |
| Cardiac Science, Inc. | Current | |
| Southern Illinois University | B.A. In Political Science | Former |
| Organization | Position | Status |
|---|---|---|
| Cardiac Science, Inc. | Current | |
| Primus Knowledge Solutions, Inc. | Vice President of Engineering | Former |
| California Institute of Technology | Ph.D. in Geophysics | Former |
| University of California, Riverside | B.S. in Physics | Former |
| Organization | Position | Status |
|---|---|---|
| Cardiac Science, Inc. | Current | |
| Stanford University | M.S. in engineering and an M.B.A. in finance and systems analysis | Former |
| Carnegie Mellon University | B.S. in engineering | Former |
| Organization | Position | Status |
|---|---|---|
| Procyte Corporation | Director, President and Chief Executive Officer | Current |
| Cardiac Science, Inc. | Current | |
| PhotoMedex, Inc. | Board of Directors | Current |
| Procyte Corporation | Board of Directors | Current |
| Escalon Medical Corp. | Director | Current |
| Safeguard Scientifics, Inc. | Advisory Member | Current |
| Endologix Inc. | Director | Current |
| Cardiac Science Corporation | Board of Directors | Current |
| Kensey Nash Corporation | CEO | Former |
| PhotoMedex, Inc. | CEO | Former |
| Kensey Nash Corporation | President | Former |
| PhotoMedex, Inc. | President | Former |
| Azurtec, Inc. | Board Member | Former |
| La Salle University | bachelor's degree in business administration and marketing | Former |
| Organization | Position | Status |
|---|---|---|
| Cardiac Science, Inc. | Current | |
| Decrane Aircraft Holdings, Inc. | Vice President of Planning and Business Development | Former |
| Minimed, Inc. | Director of Operations | Former |
| Minimed, Inc. | Director of Finance | Former |
| Anderson School of Management | M.B.A. | Former |
| Claremont McKenna College | B.A. in Economics | Former |
| Organization | Position | Status |
|---|---|---|
| Cardiac Science, Inc. | Current | |
| Dsm | Vice President | Former |
| Dsm | General Manager | Former |
| State University of New York at Buffalo | Ph.D. in Civil Engineering | Former |
| National Taiwan University | M.S. | Former |
| Organization | Position | Status |
|---|---|---|
| Cardiac Science, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| Cardiac Science, Inc. | Current | |
| University of Southern California | M.B.A. | Former |
| University of Washington | B.A. in Business Administration | Former |
| Organization | Position | Status |
|---|---|---|
| Cardiac Science, Inc. | Current | |
| Techlaw Inc. | Regional Director | Former |
| Kennesaw State University | B.B.A. in Management | Former |
| Organization | Position | Status |
|---|---|---|
| Cardiac Science, Inc. | Current | |
| Virginia Military Institute | B.A. in English | Former |
| Organization | Position | Status |
|---|---|---|
| Cardiac Science, Inc. | Current | |
| University of Washington | B.A. in History | Former |
| Organization | Position | Status |
|---|---|---|
| Cardiac Science, Inc. | Current | |
| Texas Instruments Incorporated | Former | |
| University of Michigan | Ph.D. in International Finance | Former |
| Georgia Institute of Technology | M.A. in Industrial Management | Former |
| Organization | Position | Status |
|---|---|---|
| Cardiac Science, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Cardiac Science, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Haggar Clothing Co. | Board Member | Current |
| Cardiac Science Corporation | Board Member | Current |
| Cardiac Science, Inc. | Board of Directors | Current |
| Perseus LLC | Senior Managing Director | Former |
| Morgan Stanley | General Partner | Former |
| J.H. Whitney & Co. LLC | Associate | Former |
| Morgan Stanley | Merchant Banking Department | Former |
| Stanford Graduate School of Business | M.B.A | Former |
| Stanford University | M.B.A. | Former |
| Princeton University | B.A. | Former |
| Workflow Management, Inc. | member | Former |
| Organization | Position | Status |
|---|---|---|
| Dentalview, Inc. | Current | |
| Biolife Solutions, Inc. | Director | Current |
| Elephant Talk Communications, Inc. | Board of Directors | Current |
| Cardiac Science, Inc. | Board of Directors | Current |
| Endologix Inc. | Board of Directors | Current |
| Cambridge Heart, Inc. | Chief Financial Officer | Former |
| Cardiac Science, Inc. | Chief Financial Officer & Secretary | Former |
| University of Oregon | M.B.A. | Former |
| California State University | B.A. In Economics and International Relations | Former |
Executive News
-
BRIEF: Embrella announces new CEO, new financing
-
Embrella announces new CEO, new financing
-
Jeffrey F. OĂ¢â‚¬â„¢Donnell Joins Embrella Cardiovascular, Inc. as Chief Executive Officer
-
Jeffrey F. O'Donnell Joins Embrella Cardiovascular, Inc. as Chief Executive Officer
-
Jeffrey F. O'Donnell Joins Embrella Cardiovascular, Inc. as Chief Executive Officer
Industry Transcripts by Seeking Alpha
-
51jobs Q3 2009 Earnings Call Transcript
on Nov 23, 2009about JOBS
-
NetEase Q3 2009 Earnings Call Transcript
on Nov 18, 2009about NTES
-
Franklin Covey Co. F4Q09 (Qtr End 08/31/09) Earnings Call Transcript
on Nov 16, 2009about FC
-
Cellcom Israel Ltd. Q3 2009 Earnings Call Transcript
on Nov 16, 2009about CEL
-
URS Corporation Q3 2009 Earnings Call Transcript
on Nov 13, 2009about URS


